Panacea Biotec Limited has informed the Exchange regarding a press release dated August 14, 2024, titled "Initiation of Phase III Clinical Trial of DengiAll by ICMR andPanacea Biotec Limited".
Press Release Aug 14 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Panacea Biotec
- Press Release Dec 14 2023
- Press Release Aug 22 2023
- Panacea Biotec: Audited Financial Results for quarter and financial year ended March 31, 2023
- Press Release Jan 17 2023
- Press Release Oct 10 2022
Later from Panacea Biotec
- AGM Notice Year 2023-24
- Press Release Sep 12 2024
- Press Release Jun 03 2025
- Panacea Biotec: Unaudited Financial Results for quarter ended June 30, 2025
- AGM Notice Year 2024-25
Follow Panacea Biotec into a list and get an email when it puts out news.
Follow Panacea Biotec